Human Coronavirus antigens
Showing 1–50 of 80 results
Human ACE2 (18-615) Recombinant Protein, Sheep Fc-Tag (HEK293)
Recombinant human angiotensin-converting enzyme 2 (ACE2) extracellular domain (18-615) was expressed in HEK293 cells using a C-terminal sheep Fc-tag and purified to SARS-CoV-2 receptor binding domain (RBD) of the spike protein binds to the host cell ACE2 receptor to facilitate viral entry into the cell. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
Human CD147 (BSG) Recombinant Protein, His-Tag (HEK293)
Recombinant human basigin (BSG, CD147) produced in HEK293 cells and purified from culture supernatant. There is evidence that this protein can serve as an alternative entry receptor for SARS-CoV-2. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
Human Coronavirus 229E Nucleoprotein, His-Tag (E. coli)
Human coronavirus 229E nucleoprotein is a recombinant HCoV-229E nucleocapsid protein manufactured in E. coli, with C-terminal His-tag.
Human Coronavirus 229E Purified Viral Lysate
Human coronavirus 229E viral lysate produced in cell culture and purified using sucrose density gradient ultracentrifugation. Heat-inactivated and tested for absence of viral growth in validated tissue culture infectivity assays.
Human Coronavirus 229E Spike Glycoprotein (Full-Length), Sheep Fc-Tag (HEK293)
Human coronavirus 229E spike glycoprotein is a recombinant HCoV-229E full-length spike protein, with sheep Fc-tag, manufactured in HEK293 cells, with HCoV-229E spike protein soluble domain has been C-terminally tagged with a sheep Fc-tag. Amino acids 533-540 have been replaced with 9 AA glycine-serine linker to prevent protein cleavage by host cell proteases.
Human Coronavirus 229E Spike Glycoprotein (S1), His-Tag (HEK293)
Human coronavirus 229E spike glycoprotein is a recombinant HCoV-229E spike subunit 1 protein (S1) with a C-terminus His-tag. This antigen is manufactured in HEK293 cells, with
Human Coronavirus 229E Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293)
Human coronavirus 229E spike glycoprotein is a recombinant HCoV-229E spike subunit 1 protein (S1), with sheep Fc-tag. This antigen is manufactured in HEK293 cells.
Human Coronavirus HKU1 Nucleoprotein, His-Tag (E. coli)
Human coronavirus HKU1 nucleoprotein is a recombinant HCoV-HKU1 nucleocapsid protein, with a 6His-tag. This antigen is manufactured in E. coli cells, with high purity.
Human Coronavirus HKU1 Spike Glycoprotein (Full-Length), Sheep Fc-Tag (HEK293)
Human coronavirus HKU1 full-length spike glycoprotein is a recombinant HCoV-HKU1 spike protein with sheep Fc-tag, manufactured in HEK293 cells.
Human Coronavirus HKU1 Spike Glycoprotein (S1), His-Tag (HEK293)
Human coronavirus HKU1 spike glycoprotein is a recombinant HCoV-HKU1 spike subunit 1 protein (S1), with C-terminus His-tag. This antigen is manufactured in HEK293 cells, with
Human Coronavirus NL63 Nucleoprotein, His-Tag (E. coli)
Human Coronavirus NL63 nucleoprotein is a recombinant protein containing the full-length HCoV-NL63 nucleocapsid, cloned and expressed in E. coli with a C-terminal His-tag, and purified by affinity chromatography.
Human Coronavirus NL63 Purified Viral Lysate
Human coronavirus NL63 viral lysate produced from Vero cells and purified using sucrose density gradient ultracentrifugation. Heat-inactivated and tested for absence of viral growth in validated tissue culture infectivity assays.
Human Coronavirus NL63 Spike Glycoprotein (Full-Length), Sheep Fc-Tag (HEK293)
Human coronavirus NL63 full-length spike glycoprotein is a recombinant HCoV-NL63 spike protein, with sheep Fc-tag. This antigen is manufactured in HEK293 cells, with greater than % purity.
Human Coronavirus NL63 Spike Glycoprotein (S1), His-Tag (HEK293)
Human coronavirus NL63 spike glycoprotein is a recombinant HCoV-NL63 spike subunit 1 protein (S1), with C-terminus His-tag. This antigen is manufactured in HEK293 cells, with
Human Coronavirus OC43 Nucleoprotein, His-Tag (E. coli)
Human coronavirus OC43 nucleoprotein is a recombinant HCoV-OC43 nucleocapsid protein, with 6xHis-tag. This antigen is manufactured in E. coli cells, with
Human Coronavirus OC43 Purified Viral Lysate
Human coronavirus OC43 viral lysate produced from HCT-8 cells and purified using sucrose density gradient ultracentrifugation. Heat-inactivated and tested for absence of viral growth in validated tissue culture infectivity assays.
Human Coronavirus OC43 Spike Glycoprotein (Full-Length), Sheep Fc-Tag (HEK293)
Human coronavirus OC43 full-length spike glycoprotein is a recombinant HCoV-OC43 spike protein, with sheep Fc-tag. This antigen is manufactured in HEK293 cells, with
Human Coronavirus OC43 Spike Glycoprotein (S1), His-Tag (HEK293)
Human coronavirus OC43 spike glycoprotein is a recombinant HCoV-OC43 spike subunit 1 protein (S1), with a C-terminus His-tag. This antigen is manufactured in HEK293 cells, with
MERS Coronavirus Spike Glycoprotein (S1), Camel Fc-Tag (HEK293)
MERS Coronavirus Spike (S1) glycoprotein, a recombinant protein with N-terminal camel Fc-tag, manufactured in mammalian HEK293 cells.
MERS Coronavirus Spike Glycoprotein (S1), His-Tag (Insect Cells)
MERS-CoV Spike Glycoprotein (S1) is a recombinant Middle Eastern Respiratory Syndrome (MERS) coronavirus (CoV) Spike subunit 1 protein (S1), with C-terminal His-tag.
SARS Coronavirus Envelope Protein (E. coli)
SARS Coronavirus Envelope Protein is a recombinant antigen which contains the N-terminus (1-76 amino acids) of the Envelope protein immunodominant regions. It is manufactured in E. coli and is immunoreactive with sera from SARS-infected individuals.
SARS Coronavirus Membrane Protein (Matrix) (E. coli)
SARS Coronavirus Membrane Protein (Matrix) is a recombinant protein (also known as E1 glycoprotein or Matrix) manufactured in E. coli. Protein contains duplicate Membrane immunodominant region sequences fused with a proprietary linker and His-tag. Immunoreactive with sera from SARS-infected individuals.
SARS Coronavirus Nucleoprotein (C-Term) (E. coli)
SARS Coronavirus Nucleoprotein (C-Term) is a recombinant protein (also known as the nucleocapsid core antigen) comprising amino acids 340-390 immunodominant regions. it is manufactured in E. coli, with Immunoreactive with sera from SARS-infected individuals with minimum specificity problems.
SARS Coronavirus Nucleoprotein (N-Term) (E. coli)
SARS Coronavirus Nucleoprotein (N-Term) is a recombinant protein (also known as the nucleocapsid core antigen) comprising amino acids 1-49 immunodominant regions. It is manufactured in E. coli and immunoreactive with sera from SARS-infected individuals.
SARS Coronavirus Nucleoprotein, His-Tag (HEK293)
SARS Coronavirus Nucleoprotein (AA 2-422) is a recombinant antigen manufactured in HEK293 cells for use in vaccine research and immunoassay development.
SARS Coronavirus Spike Glycoprotein (S1), His-Tag (HEK293)
SARS Coronavirus Spike Glycoprotein (S1) is a recombinant antigen which contains amino acids 1-666 of S1 subunit. It is manufactured in mammalian HEK293 cells with
SARS-CoV-2 (B.1.1.28) Spike Glycoprotein (S1) RBD, His-Tag (HEK293)
BRAZILIAN (GAMMA) VARIANT SARS-CoV-2 spike receptor binding domain (RBD) from Brazilian variant. Contains amino acid changes K417T, E484K, N501Y relative to Wuhan Hu-1. The protein was produced in HEK293 cells and purified from culture supernatant. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.1.28/P.1) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293)
BRAZILIAN (GAMMA) VARIANT Pre-fusion stabilized SARS-CoV-2 Spike protein of the virus variant B.1.1.28/P1 (Brazilian variant) containing amino acid changes L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I, V1176F relative to Wuhan Hu-1. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.1.529/Omicron) Nucleoprotein, His-Tag (E. coli)
OMICRON VARIANT SARS-CoV-2 (B.1.1.529/Omicron) nucleoprotein is a recombinant Omicron NP expressed and purified from E. coli. Compared to wild type SARS-CoV-2 nucleoprotein, Omicron nucleoprotein has the following mutations, P13L, ∆31-33, R203K, G204R. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1) RBD, His-Tag (HEK293)
OMICRON VARIANT SARS-CoV-2 (B.1.1.529/Omicron) Spike RBD (receptor binding domain) protein. Relative to Wuhan-Hu-1 this protein has following amino acid changes: G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H. Biotinylated protein also available. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293)
OMICRON VARIANT SARS-CoV-2 (B.1.1.529/Omicron) Spike subunit 1 protein. Relative to Wuhan-Hu-1 this protein has following amino acid changes: A67V, H69del, V70del, T95I, G142D, V143del, Y144del, Y145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y. Biotinylated protein available. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.1.529/Omicron) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293)
OMICRON VARIANT SARS-CoV-2 (B.1.1.529/Omicron) stabilized spike recombinant protein. Relative to Wuhan-Hu-1 the protein has amino acid changes A67V, H69del, V70del, T95I, G142D, V143del, Y144del, Y145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F. The furin cleavage site has been altered to GSAS, and the protein has 6 amino acid changes in the S2 portion to stabilize trimer formation, commonly known as HexaPro. The C-terminus contains a T4 foldon domain. Biotinylated protein available. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.1.7 + E484K) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293)
UNITED KINGDOM (ALPHA) VARIANT Pre-fusion stabilized SARS-CoV-2 Spike protein of the 'New Kent'; variant B.1.1.7 containing amino acid change E484K (in addition to 69-70del, Y144del, N501Y, A570D, P681H, T716I, S982A, D1118H). SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease. Lineage B.1.1.7 (Variant of Concern 202012/01) is correlated with a significant increase in the rate of COVID-19 infection in the UK.
SARS-CoV-2 (B.1.1.7) Spike Glycoprotein (Full-Length), His-Tag (HEK293)
UNITED KINGDOM (ALPHA) VARIANT SARS-CoV-2 Spike protein that contains all amino acid changes of the “UK variant” B.1.1.7 of SARS-CoV-2: 69-70del, Y144del, N501Y, A570D, P681H, T716I, S982A, D1118H relative to Wuhan-Hu-1. This construct has a functional furin cleavage site. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.1.7) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293)
UNITED KINGDOM (ALPHA) VARIANT SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease. Lineage B.1.1.7 (Variant of Concern 202012/01) is correlated with a significant increase in the rate of COVID-19 infection in the UK and includes amino acid substitutions 69-70del, Y144del, N501Y, A570D, P681H, T716I, S982A, D1118H relative to the prototypic Wuhan-Hu-1 strain.
SARS-CoV-2 (B.1.351) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293)
SOUTH AFRICAN (BETA) VARIANT SARS-CoV-2 (B.1.351) stabilized spike glycoprotein, from the South Africa variant. It contains amino acid changes L18F, D80A, D215G, del242-244, K417N, E484K, N501Y, D614G, and A701V, relative to Wuhan-Hu-1. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.351/501.V2) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293)
SOUTH AFRICAN (BETA) VARIANT SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease. The B.1.351/501.V2 variant, also known as 501.V2, 20H/501Y.V2 (formerly 20C/501Y.V2), was first detected in South Africa and includes the amino acid substitutions D80A, D215G, K417N, E484K, N501Y and A701V relative to the prototypic Wuhan-Hu-1 strain.
SARS-CoV-2 (B.1.351/501Y.V2) Spike Glycoprotein (S1) RBD, His-Tag (HEK293)
SOUTH AFRICAN (BETA) VARIANT SARS-CoV-2 spike receptor binding domain (RBD) from South African variant. Contains amino acid changes K417N, E484K, N501Y relative to Wuhan Hu-1. The protein was produced in HEK293 cells and purified from culture supernatant. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.617.1) Spike Glycoprotein (S1) RBD, His-Tag (HEK293)
KERALA (KAPPA) VARIANT SARS-CoV-2 (B.1.617.1) RBD mutant from the Kerala variant. Contains amino acid changes E484Q, L452R relative to Wuhan Hu-1. The protein was produced in HEK293 cells and purified from culture supernatant. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.617.2; AY.1, AY.2, AY.3) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293)
INDIAN (DELTA) VARIANT SARS-CoV-2 (B.1.617.2; AY.1, AY.2, AY.3) stabilized Spike from the Indian (Delta) variant. Contains T19R, T95I, G142D, E156G, del157-158, W258L, N417K, L452R, T478K, D614G, P681R, D950N mutations. The protein was produced in HEK293 cells and purified from culture supernatant. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (B.1.617.2) Spike Glycoprotein (S1) RBD, His-Tag (HEK293)
INDIAN (DELTA) VARIANT SARS-CoV-2 (B.1.617.2) RBD mutant from the Delta variant. Contains amino acid changes L452R, T478K relative to Wuhan Hu-1. The protein was produced in HEK293 cells and purified from culture supernatant. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 (N501Y Mutant) Spike Glycoprotein (S1) RBD, His-Tag (HEK293)
UNITED KINGDOM (ALPHA) VARIANT SARS-CoV-2 (N501Y mutant) spike subunit 1 (S1) receptor binding domain (RBD) is a recombinant antigen manufactured in HEK293 cells to high purity. This antigen contains N501Y amino acid change relative to the Wuhan-Hu-1 isolate. The N501Y mutation has been reported to increase binding affinity to human ACE2. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 3C-Like Proteinase (3CLpro), Active
Active recombinant full-length SARS-CoV-2 3CLpro, part of the large replicase polyprotein 1ab (S3264-Q3569), expressed in E. coli cells with an N-terminal His-tag. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 Neutralization Assay Development Kit (Brazilian Variant RBD-ACE2)
BRAZILIAN VARIANT This SARS-CoV-2 Neutralization Assay Development Kit (BZ variant RBD-ACE2) is intended for the identification and qualitative measurement of neutralizing antibodies. Kit contains enough reagents for 10 x 96-well plates. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 Neutralization Assay Development Kit (Delta Variant RBD-ACE2)
DELTA VARIANT This SARS-CoV-2 Neutralization Assay Development Kit (Delta variant RBD-ACE2) is intended for the identification and qualitative measurement of neutralizing antibodies. Kit contains enough reagents for 10 x 96-well plates. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 Neutralization Assay Development Kit (Kerala Variant RBD-ACE2)
KERALA (KAPPA/B.1.617.1) VARIANT This SARS-CoV-2 Neutralization Assay Development Kit (Kerala variant RBD-ACE2) is intended for the identification and qualitative measurement of neutralizing antibodies. Kit contains enough reagents for 10 x 96-well plates. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 Neutralization Assay Development Kit (Lambda Variant RBD-ACE2)
LAMBDA VARIANT This SARS-CoV-2 Neutralization Assay Development Kit (Lambda variant RBD-ACE2) is intended for the identification and qualitative measurement of neutralizing antibodies. Kit contains enough reagents for 10 x 96-well plates. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 Neutralization Assay Development Kit (Omicron Variant SPIKE-ACE2)
OMICRON VARIANT This SARS-CoV-2 Neutralization Assay Development Kit (Omicron variant SPIKE-ACE2) is intended for the identification and qualitative measurement of neutralizing antibodies. Kit contains enough reagents for 10 x 96-well plates. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 Neutralization Assay Development Kit (RBD-ACE2)
Wild-Type (Wuhan-Hu-1) This SARS-CoV-2 Neutralization Assay Development Kit (RBD-ACE2) is intended for the identification and qualitative measurement of neutralizing antibodies. Kit contains enough reagents for 10 x 96-well plates. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
Powered by Bioz